Mithra Pharmaceuticals S.A. | Mutual Funds
Mutual Funds that own Mithra Pharmaceuticals S.A.
BNP Paribas B - Pension Balanced
137,825
0.37%
0
0.16%
09/29/2017
68,262
0.18%
0
0.73%
07/31/2018
iShares MSCI EAFE Small Cap ETF
57,957
0.15%
0
0.02%
09/06/2018
Metropolitan - Rentastro Growth
49,945
0.13%
0
0.21%
07/31/2018
River & Mercantile Funds ICVC - World Recovery Fund
36,948
0.1%
36,948
0.3%
09/30/2017
MainStay International Opportunities Fund
33,336
0.09%
33,336
0.19%
06/29/2018
30,900
0.08%
0
3.1%
12/31/2017
iShares MSCI EMU Small Cap UCITS ETF
24,227
0.06%
0
0.09%
09/06/2018
18,912
0.05%
18,912
0.53%
09/30/2017
SEI Global Master Fund Plc - Pan European Small Cap Equity
17,141
0.05%
17,141
0.21%
06/30/2018
| Address |
Rue Saint-Georges 5
Liege WA 4000
Belgium
|
|
Employees
|
- |
| Website |
http://www.mithra.com |
| Updated |
07/08/2019 |
| Mithra Pharmaceuticals SA engages in the development, manufacture, and commercialization of proprietary and differentiated drugs and generic products dedicated to female healthcare. It specializes in the following domains of health for women: contraception and fertility, menopause and osteoporosis, gynecological infections, and cancers. The company was founded by Jean-Michel Foidart and François Fornieri on July 8, 1999 and is headquartered in Liège, Belgium. |
